ACX-22003-18556 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-15
Dose 1 — Pfizer-BioNTech
2021-02-05
Dose 2 — Pfizer-BioNTech
2021-09-24
Dose 3 — Pfizer-BioNTech
2022-05-14
Dose 4 — Pfizer-BioNTech
2022-05-15
Registered in v-safe
2022-05-15
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-05-16
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-05-17
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches

Adult check-in
2022-05-18
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-05-19
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-05-20
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-05-21
Health check-in — day 7, dose 4
Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-05-28
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-06-05
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-06-13
Health check-in — day 28, dose 4
Feeling: Fair

Adult check-in
2022-06-20
Survey response — day 35, dose 4
MedDRA: Bronchitis — Feeling: Fair · Be unable to do your normal daily activities

Free text: Bronchitis

MedDRA releases: 2024-11 · check-in free text available
2022-06-25
Health check-in — day 42, dose 4
Feeling: Fair

Adult check-in
2022-08-13
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2022-11-13
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in
2023-05-16
Survey response — 12 months, dose 4
MedDRA: Bronchitis, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-05-16
Report sent to call center — 12 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-05-17
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-15	Pfizer-BioNTech	No
2	2021-02-05	Pfizer-BioNTech	No
3	2021-09-24	Pfizer-BioNTech	No
4	2022-05-14	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 — day 35, dose 4

2022-06-20

Symptoms: Bronchitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Bronchitis	·	·	✓
SD	Sinusitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release